The adhesion of blood leukocytes to the vascular endothelium is an essential step in a variety of pathophysiological process. During the past project period, two inducible adhesion molecules were identified and characterized in detail in this Program Project. Both endothelial- leukocyte adhesion molecule-I (ELAM-1 or E-selectin) and vascular cell adhesion molecule (VCAM-1) are expressed by cultured endothelium after exposure to the cytokines interleukin-1beta or tumor necrosis factor- alpha. ELAM-1 is selectively expressed on human vascular endothelium in microvessels at sites of inflammation. VCAM-1 is a mononuclear-selective leukocyte adhesion molecule expressed by endothelial cells at sites of immune and non-immune inflammatory responses and atherosclerosis, as well as by dendritic cells. Detailed understanding of the regulation of expression of these cytokine-induced molecules may provide important insights into the control of inflammatory/immune processes.
Specific Aim 1 : Determine the role of NF-kB family members in the cytokine-induced activation and repression of ELAM-1 gene expression.
Specific Aim 2 : Characterize the endothelial inhibitors of NF-kB capable of regulating the cytokine-induced expression of the ELAM-1 gene.
Specific Aim 3 : To assemble several human ELAM-1 minigenes, insert these constructs into the germ line of mice and explore the pattern of transgene expression in several vascular beds in models of endothelial activation.
Showing the most recent 10 out of 261 publications
